Mutations, drugs drive cancer by blurring growth signals: Researchers control common cancer pathway in lab with pulses of light

Genetic mutations in a form of non-small cell lung cancer (NSCLC) may drive tumor formation by blurring cells' perception of key growth signals, according to a new laboratory study. The research could have important implications for understanding and ultimately targeting the defective mechanisms underlying many human cancers.

  • 0 Likes

  • 0 Comments

See posts by others with similar interest

You may be interested in

Tell others about your work

105+

Scraps written yesterday

Your works only be popular when others learn about your work.

Terms . Privacy . Help . Newsroom . Contact Us

MachPrinciple © 2020